Lymphadenopathy in patients with multiple sclerosis undergoing treatment with glatiramer acetate.
Windhagen
A
A
Maniak
S
S
Marckmann
S
S
Lindert
R B
RB
Heidenreich
F
F
Blasczyk
R
R
D000068717:Glatiramer Acetate; D006801:Humans; D008206:Lymphatic Diseases / Q000209:etiology*; D009103:Multiple Sclerosis / Q000150:complications* / Q000188:drug therapy*; D010455:Peptides / Q000009:adverse effects / Q000627:therapeutic use*
D010455:Peptides; D000068717:Glatiramer Acetate